/Revvity%20Inc_%20logo%20on%20phone%20and%20site%20by-%20T_Schneier%20via%20Shutterstock.jpg)
Revvity, Inc. (RVTY), based in Waltham, Massachusetts, is a leading global provider of life sciences and diagnostics solutions. Valued at a market capitalization of $13.6 billion, the company specializes in innovative products and services that drive advancements in scientific research, healthcare, and diagnostics, playing a vital role in improving patient outcomes and supporting medical science breakthroughs.
Shares of RVTY have underperformed the broader market considerably over the past year. RVTY has gained 27.3% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 31.3%. Also, in 2024, the stock is up 4.9%, compared to the SPX’s 25.5% rise on a YTD basis.